HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manoli Vourvahis Selected Research

UK 453,061

11/2012Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
2/2012Pharmacokinetic effects of coadministration of lersivirine with raltegravir or maraviroc in healthy subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manoli Vourvahis Research Topics

Disease

5Infections
01/2022 - 01/2009
2Fibrosis (Cirrhosis)
01/2022 - 09/2008
1Breast Neoplasms (Breast Cancer)
01/2022
1Atopic Dermatitis (Atopic Eczema)
01/2022
1Fatty Liver
01/2022
1Alcoholic Fatty Liver
01/2022
1Intraabdominal Infections
01/2022
1Ventilator-Associated Pneumonia
01/2022
1Urinary Tract Infections (Urinary Tract Infection)
01/2022
1Virus Diseases (Viral Diseases)
01/2020
1COVID-19
01/2020
1Orthostatic Hypotension (Postural Hypotension)
05/2019
1Hepatitis C
04/2014
1Chronic Kidney Failure (Chronic Renal Failure)
05/2013
1Hyperbilirubinemia
02/2013
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2012
1Non-alcoholic Fatty Liver Disease
09/2008
1Liver Diseases (Liver Disease)
09/2008
1Erectile Dysfunction
06/2007

Drug/Important Bio-Agent (IBA)

3MaravirocFDA Link
01/2019 - 01/2009
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2022 - 06/2007
2Protease Inhibitors (Protease Inhibitor)IBA
04/2014 - 06/2007
2Reverse Transcriptase InhibitorsIBA
11/2012 - 02/2012
2UK 453,061IBA
11/2012 - 02/2012
1Organic Cation Transporter 1IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1ceftazidime drug combination avibactamIBA
01/2022
1Organic Anion TransportersIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1abrocitinibIBA
01/2022
1ketohexokinaseIBA
01/2022
1Janus Kinase 1IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1AnionsIBA
01/2022
1LactamsIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Chloroquine (Aralen)FDA LinkGeneric
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Azithromycin (Zithromax)FDA LinkGeneric
01/2020
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2020
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
05/2019
1Cytochrome P-450 CYP3AIBA
01/2019
1Transaminases (Aminotransferases)IBA
02/2013
1NucleosidesIBA
11/2012
1Methadone (Dolophine)FDA LinkGeneric
11/2012
1Opioid Analgesics (Opioids)IBA
11/2012
1FlavonolignansIBA
09/2008
1Caspase 3 (Caspase-3)IBA
09/2008
1Silybin (Lagosa)IBA
09/2008
1silychristinIBA
09/2008
1SilymarinIBA
09/2008
1tipranavirFDA Link
06/2007
1Tryptamines (Triptans)IBA
06/2007
1Ritonavir (Norvir)FDA Link
06/2007
1Histamine Antagonists (Antihistamines)IBA
06/2007
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2007
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
06/2007

Therapy/Procedure

3Therapeutics
01/2022 - 05/2019